Go Pro
NASDAQ:XOMAP

XOMA (XOMAP) Stock Price, News & Analysis

XOMA logo
$24.98 0.00 (0.00%)
As of 07/31/2026

About XOMA Stock (NASDAQ:XOMAP)

Advanced

Key Stats

Today's Range
$24.98
$24.98
50-Day Range
$24.97
$25.52
52-Week Range
$24.93
$30.00
Volume
N/A
Average Volume
2,224 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
8.65%
Price Target
N/A
Consensus Rating
N/A

Company Overview

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions. In addition to its flagship candidate, XOMA is advancing earlier-stage antibody drug candidates targeting other immune pathways in preclinical development. These efforts aim to address both orphan and more prevalent indications, reflecting the company’s commitment to delivering innovative biologics to patients with unmet medical needs.

Founded in 1981 and headquartered in Berkeley, California, XOMA has cultivated strategic collaborations with major pharmaceutical partners to co-develop and license antibody programs. The company’s operations extend primarily across the United States, with regulatory and clinical development activities also underway in Europe and other regions. XOMA is led by a management team with extensive experience in antibody drug discovery and clinical development.

AI Generated. May Contain Errors.

Receive XOMAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XOMAP Stock News Headlines

XOMA (XOMAP) to Announce Earnings on Thursday
XOMA Royalty Corp.
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
Xoma AB Series B
LGND: XOMA Buy Adds 100+ Assets
Ligand to buy XOMA Royalty for $39/share
See More Headlines

XOMAP Stock Analysis - Frequently Asked Questions

XOMA's stock was trading at $26.8690 at the beginning of 2026. Since then, XOMAP shares have decreased by 7.0% and is now trading at $24.98.

Shares of XOMAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 7/14 Dividend
7/02/2026
Ex-Dividend for 7/14 Dividend
7/02/2026
Dividend Payable
7/14/2026
Today
8/03/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:XOMAP
CIK
791908
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$7.65 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:XOMAP) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners